Esther Cabrero

629 total citations
22 papers, 479 citations indexed

About

Esther Cabrero is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Esther Cabrero has authored 22 papers receiving a total of 479 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 9 papers in Virology and 5 papers in Emergency Medicine. Recurrent topics in Esther Cabrero's work include HIV Research and Treatment (9 papers), HIV/AIDS Research and Interventions (9 papers) and HIV/AIDS drug development and treatment (9 papers). Esther Cabrero is often cited by papers focused on HIV Research and Treatment (9 papers), HIV/AIDS Research and Interventions (9 papers) and HIV/AIDS drug development and treatment (9 papers). Esther Cabrero collaborates with scholars based in Spain, United States and United Kingdom. Esther Cabrero's co-authors include Michael Norton, José Antonio Iribarren, José Ramón Arribas, Federico Pulido, Antonio de la Hera, Marı́a L. Toribio, Juan Pasquau, Maria Jesús Pérez‐Elías, Carlos Márquez and Juan González‐García and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and European Journal of Immunology.

In The Last Decade

Esther Cabrero

22 papers receiving 458 citations

Peers

Esther Cabrero

VIROL

EPIDE

IMMUN

Nitiya Chomchey Thailand

Caiping Guo China

Markus Vogt Ukraine

Maria Luisa Fusi Italy

Lorna Leal Spain

Joanna Peterkin United States

John Thornhill United Kingdom

Stefania Ruzzante Italy

P Lorenzini Italy

Thomas A. Premeaux United States

Nitiya Chomchey Thailand

Esther Cabrero

508 ×1.6

438 ×2.0

VIROL

106 ×0.8

278 ×3.7

EPIDE

56 ×0.8

IMMUN

Citations per year, relative to Esther Cabrero Esther Cabrero (= 1×) peers Nitiya Chomchey

Countries citing papers authored by Esther Cabrero

Since Specialization

Citations

This map shows the geographic impact of Esther Cabrero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esther Cabrero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esther Cabrero more than expected).

Fields of papers citing papers by Esther Cabrero

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esther Cabrero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esther Cabrero. The network helps show where Esther Cabrero may publish in the future.

Co-authorship network of co-authors of Esther Cabrero

This figure shows the co-authorship network connecting the top 25 collaborators of Esther Cabrero. A scholar is included among the top collaborators of Esther Cabrero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esther Cabrero. Esther Cabrero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Robertson, Kevin, Carmen Bayón, Jean‐Michel Molina, et al.. (2014). Screening for neurocognitive impairment, depression, and anxiety in HIV-infected patients in Western Europe and Canada. AIDS Care. 26(12). 1555–1561. 82 indexed citations

Bayón, Carmen, et al.. (2012). Prevalence of Depressive and Other Central Nervous System Symptoms in HIV-Infected Patients Treated with HAART in Spain. Journal of the International Association of Physicians in AIDS Care. 11(5). 321–328. 15 indexed citations

Elbirt, Daniel, Carmen Bayón, K. Robertson, et al.. (2012). Neurocognitive impairment, depression, and anxiety in HIV‐1‐infected patients across western Europe and Canada: the CRANIum study ‐ ethnicity analysis. Journal of the International AIDS Society. 15(S4). 1–2. 4 indexed citations

Cabrero, Esther, et al.. (2010). Prevalence and Impact of Body Physical Changes in HIV Patients Treated with Highly Active Antiretroviral Therapy: Results from a Study on Patient and Physician Perceptions. AIDS Patient Care and STDs. 24(1). 5–13. 38 indexed citations

Macı́as, Juan, J González, Enrique Ortega, et al.. (2010). Use of simple noninvasive biomarkers to predict liver fibrosis in HIV/HCV coinfection in routine clinical practice. HIV Medicine. 11(7). 439–447. 15 indexed citations

Pulido, Federico, José Ramón Arribas, Rafaël Delgado, et al.. (2008). Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and two nucleosides for maintenance therapy of HIV. AIDS. 22(2). F1–F9. 120 indexed citations

Tural, Cristina, et al.. (2008). Cross-sectional study to determine prevalence of significant liver fibrosis (F2–F4) in HIV/HCV co-infected patients: GRAFIHCO study. Journal of the International AIDS Society. 11(Suppl 1). P264–P264. 2 indexed citations

Resino, Salvador, Isabel Galán, Alicia Pérez, et al.. (2005). Immunological Changes after Highly Active Antiretroviral Therapy with Lopinavir–Ritonavir in Heavily Pretreated HIV-Infected Children. AIDS Research and Human Retroviruses. 21(5). 398–406. 9 indexed citations

Ramos, José Tomás, María Isabel de José, Clàudia Fortuny, et al.. (2005). Safety and Antiviral Response at 12 Months of Lopinavir/Ritonavir Therapy in Human Immunodeficiency Virus-1-Infected Children Experienced With Three Classes of Antiretrovirals. The Pediatric Infectious Disease Journal. 24(10). 867–873. 15 indexed citations

10.

Resino, Salvador, José M. Bellón, José Tomás Ramos, et al.. (2004). Positive virological outcome after lopinavir/ritonavir salvage therapy in protease inhibitor-experienced HIV-1-infected children: a prospective cohort study. Journal of Antimicrobial Chemotherapy. 54(5). 921–931. 10 indexed citations

11.

Galán, Isabel, Javier López Jiménez, Milagros González‐Rivera, et al.. (2004). Virological phenotype switches under salvage therapy with lopinavir–ritonavir in heavily pretreated HIV-1 vertically infected children. AIDS. 18(2). 247–255. 21 indexed citations

12.

Resino, Salvador, José M. Bellón, José Tomás Ramos, et al.. (2004). Salvage Lopinavir-Ritonavir Therapy in Human Immunodeficiency Virus-Infected Children. The Pediatric Infectious Disease Journal. 23(10). 923–930. 16 indexed citations

13.

Moreno, Santiago, Daniel Podzamczer, José Antonio Iribarren, et al.. (2001). Treatment of tuberculosis in HIV-infected patients: safety and antiretroviral efficacy of the concomitant use of ritonavir and rifampin. AIDS. 15(9). 1185–1187. 26 indexed citations

14.

Osuna, Eduardo, et al.. (1996). Prevalencia del abuso de alcohol en una población laboral del sector pesquero. 8(3). 267–276. 2 indexed citations

15.

Cabrero, Esther, et al.. (1993). Differential Capacity of Various Anti-Ig Reagents to Synergize with Interleukin-4 to Induce Clonal Expansion in Resting and Activated B Cells. Immunobiology. 189(5). 472–482. 1 indexed citations

16.

Cabrero, Esther, María J. Sánchez, & Carmen Gutiérrez. (1992). The requirements for growth of in vivo activated autoimmune B cells are similar to those of in vitro generated lipopolysaccharide B cell blasts and dissimilar to anti-IgM plus IL-4 induced B lymphoblasts. Journal of Autoimmunity. 5(3). 289–303. 2 indexed citations

17.

Gutiérrez, Cristina, et al.. (1991). Lack of Correlation between in vitro Immunological Alterations and the Development of Scleroderma-Like Skin Lesions in Toxic Oil Syndrome Patients. Dermatology. 183(2). 123–128. 1 indexed citations

18.

Díaz‐Meco, María T., S Quiñones, M.M. Municio, et al.. (1991). Protein kinase C-independent expression of stromelysin by platelet-derived growth factor, ras oncogene, and phosphatidylcholine-hydrolyzing phospholipase C.. Journal of Biological Chemistry. 266(33). 22597–22602. 34 indexed citations

19.

Hera, Antonio de la, et al.. (1986). Differentiation of human mature thymocytes: Existence of a T3⁺4⁻8⁻ intermediate stage. European Journal of Immunology. 16(6). 653–658. 28 indexed citations

20.

Toribio, Marı́a L., Maria Carmen Martínez, María Ángeles Marcos, et al.. (1986). A role for T3+4-6-8- transitional thymocytes in the differentiation of mature and functional T cells from human prothymocytes.. Proceedings of the National Academy of Sciences. 83(18). 6985–6988. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact